The mice model market has seen significant advancements and is anticipated to continue its upward trajectory, driven by the increasing need for biomedical research and the development of innovative treatments. This article delves into the growth, size, share, and trends shaping this vital market segment.
The global Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029.
Key players in the global mice model market include Charles River Laboratories (US), Inotiv (US), THE JACKSON LABORATORY (US), GemPharmatech (China), Cyagen (US), Shanghai Model Organisms Center, Inc. (China), JSR Corporation (Japan), Biocytogen (China), TRANS GENIC INC. (Japan), Ozgene Pty Ltd. (Australia), Taconic Biosciences, Inc. (US), TransCure bioServices (France), Harbour BioMed (China), Marshall BioResources (US), genOway (France), Vivo Bio Tech Ltd. (India), ingenious targeting laboratory (US), Janvier Labs (France), Applied StemCell (US), Creative Animodel (US), JOINN Laboratories Co., Ltd. (China), Creative Biolabs (US), Crescendo Biologics (UK), Aragen Life Sciences (India), and PolyGene (Switzerland).
Download the PDF Brochure at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1308
Market Growth
The mice model market is experiencing robust growth, propelled by extensive research activities in oncology, immunology, and neurology. The demand for genetically engineered mice, capable of mimicking human diseases, has surged, providing invaluable insights into disease mechanisms and therapeutic interventions. The pharmaceutical and biotechnology industries are major contributors, utilizing mice models for drug discovery and development, leading to a substantial increase in market growth.
Market Size
In recent years, the global mice model market has expanded significantly. As of 2023, the market size is estimated to be worth several billion dollars, with projections indicating continuous growth in the coming years. This expansion is attributed to the rising investment in R&D activities, government funding for medical research, and the growing focus on personalized medicine.
Market Share
North America holds the largest market share, driven by the presence of key players, advanced research infrastructure, and substantial funding for biomedical research. Europe follows closely, with significant contributions from countries like the UK and Germany. The Asia-Pacific region is emerging as a lucrative market, with increasing investments in research and development, particularly in China and Japan. This region is expected to witness the fastest growth rate, attributed to the expanding pharmaceutical and biotech industries.
Emerging Trends
1. CRISPR Technology: The advent of CRISPR-Cas9 technology has revolutionized the creation of genetically modified mice models. This technology allows for precise gene editing, enabling the development of models that closely replicate human genetic disorders, thereby enhancing the accuracy of preclinical studies.
2. Humanized Mice Models: There is a growing trend towards the use of humanized mice models, which are engineered to express human genes, tissues, or immune cells. These models are crucial for studying human-specific diseases and evaluating the efficacy and safety of new drugs.
3. Personalized Medicine: The push towards personalized medicine is driving the demand for customized mice models. Researchers are developing models that reflect the genetic makeup of individual patients, providing deeper insights into disease progression and treatment responses.
4. Collaborations and Partnerships: Strategic collaborations between academic institutions, research organizations, and industry players are on the rise. These partnerships aim to accelerate the development of novel mice models and enhance the scope of biomedical research.
5. Ethical Considerations: Increasing ethical concerns regarding animal testing are pushing the market towards the development of alternative methods. However, the irreplaceable role of mice models in biomedical research ensures their continued relevance, albeit with stricter regulatory oversight and improved welfare standards.
Get a FREE Sample Report with Detailed TOC at https://www.marketsandmarkets.com/requestsampleNew.asp?id=1308
In conclusion, the mice model market is poised for significant growth, driven by technological advancements, increasing research activities, and the continuous demand for innovative therapeutic solutions. As trends like CRISPR technology and personalized medicine gain traction, the market is set to evolve, offering new opportunities and challenges for stakeholders in the biomedical research landscape.
Comments
0 comment